Skip to content

clinical and microbiological efficacy of arimedadi oil

â??A Clinical And Microbiological Evaluation Of Arimedadi Oil With 0.2% Chlorhexidine Gluconate Mouthwash As An Adjuvant To Scaling In Chronic Gingivitis â??A Randomized Controlled Trialâ??

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033384
Enrollment
45
Registered
2021-05-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: scaling: subjects will undergo scaling alone at baseline followed by standard oral hygiene instructions. Control Intervention1: Arimedadi oil mouthrinse with scaling: 10ml of arimedadi

Sponsors

Umme kulsum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with chronic gingivitis GI score > 0.1and PI score >= 1 2. Subjects with age group of 19 to 64 years. 3. Subjects having minimum of 20 teeth in the oral cavity. 4. Systemically healthy patients. 5. Subjects who give informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Subjects undergoing fixed orthodontic treatment or prosthesis. 2. Subjects who have undergone periodontal surgical or non-surgical treatment 6 months prior to the study. 3. Subjects using any form of adjunctive chemotherapeutic agents. 4. History of systemic antibiotic administration within 3 months prior to the study or any other regular medication. 5. Pregnancy and Lactation 6. Subjects with history of tobacco chewing, alchohol consumption and smoking. 7. History of allergy to chlorhexidine or any other herbal products.

Design outcomes

Primary

MeasureTime frame
o To evaluate the efficacy of Arimedadi oil as an adjuvant to scaling on clinical and microbiological parameters.Timepoint: baseline,14th day and 21st day

Secondary

MeasureTime frame
o To evaluate the efficacy of 0.2% Chlorhexidine gluconate mouthwash as an adjuvant to scaling on clinical and microbiological parameters.Timepoint: baseline,14th day and 21st day;o To evaluate the efficacy of scaling alone on clinical and microbiological parameters.Timepoint: baseline,14th day and 21st day

Countries

India

Contacts

Public ContactUMME KULSUM

YENEPOYA DENTAL COLLEGE

drvinitaboloor@gmail.com9845114652

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026